These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21438846)

  • 1. The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy.
    Nomura S; Fujita S; Ozasa R; Nakanishi T; Miyaji M; Mori S; Ito T; Ishii K
    Platelets; 2011; 22(5):396-7. PubMed ID: 21438846
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
    Kawasugi K
    Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
    [No Abstract]   [Full Text] [Related]  

  • 4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombomodulin-relationship thrombotic marker and therapeutic effect].
    Nomura S
    Rinsho Byori; 2011 Feb; Suppl 147():188-93. PubMed ID: 21761770
    [No Abstract]   [Full Text] [Related]  

  • 6. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
    Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of platelet counting by automated hematologic analyzers in acute leukemia and disseminated intravascular coagulation: potential effects of platelet activation.
    Kim SY; Kim JE; Kim HK; Han KS; Toh CH
    Am J Clin Pathol; 2010 Oct; 134(4):634-47. PubMed ID: 20855645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serum high mobility group box 1 in hematological malignancies complicated with systemic inflammatory response syndrome and effect of recombinant thrombomodulin.
    Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Sakai H; Kato M; Takahashi M; Miura I
    Leuk Lymphoma; 2013 Sep; 54(9):1953-8. PubMed ID: 23339448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.
    Takeuchi M; Tanoshima R; Miyagawa N; Sarashina T; Kato H; Kajiwara R; Ito S; Goto H
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27734584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
    Nomura S; Iishii K; Inami N; Kimura E; Urase F
    Pathophysiol Haemost Thromb; 2007; 36(1):32-9. PubMed ID: 18332612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
    Ikezoe T; Takeuchi A; Chi S; Takaoka M; Anabuki K; Kim T; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Eur J Haematol; 2013 Nov; 91(5):442-7. PubMed ID: 23952647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T; Matsuo M; Sugimoto T; Wanaka K
    Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
    Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
    Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects.
    Tsuruta K; Yamada Y; Serada M; Tanigawara Y
    J Clin Pharmacol; 2011 Sep; 51(9):1276-85. PubMed ID: 21098690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".
    Wada H; ; Okamoto K; Iba T; Kushimoto S; Kawasugi K; Gando S; Madoiwa S; Uchiyama T; Mayumi T; Seki Y
    Thromb Res; 2014 Oct; 134(4):924-5. PubMed ID: 25135793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
    Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
    Tallman MS; Kwaan HC
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
    Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
    Hatada T; Wada H; Nobori T; Okabayashi K; Maruyama K; Abe Y; Uemoto S; Yamada S; Maruyama I
    Thromb Haemost; 2005 Nov; 94(5):975-9. PubMed ID: 16363239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.